Ingrid Yao Mattisson

498 total citations
18 papers, 370 citations indexed

About

Ingrid Yao Mattisson is a scholar working on Immunology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ingrid Yao Mattisson has authored 18 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Molecular Biology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ingrid Yao Mattisson's work include Atherosclerosis and Cardiovascular Diseases (8 papers), Cell death mechanisms and regulation (3 papers) and Systemic Lupus Erythematosus Research (3 papers). Ingrid Yao Mattisson is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (8 papers), Cell death mechanisms and regulation (3 papers) and Systemic Lupus Erythematosus Research (3 papers). Ingrid Yao Mattisson collaborates with scholars based in Sweden, United States and Italy. Ingrid Yao Mattisson's co-authors include Jan Nilsson, Maria Wigren, Christina Christoffersen, Gunilla Nordin Fredrikson, Harry Björkbacka, Gunnar Engström, Sara Rattik, Eva Bengtsson, Isabel Gonçalves and Marju Orho‐Melander and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ingrid Yao Mattisson

18 papers receiving 366 citations

Peers

Ingrid Yao Mattisson

IMMUN

RHEUM

CCM

EPIDE

Raffaele Capoano Italy

Satu Lehti Finland

Luca Pacini Italy

Sibel Oğuzkan Balcı Türkiye

Sara Rattik Sweden

Christoph Leib Germany

Motasem Melhem Kuwait

Mascha Koenen Germany

Yujie Zhou China

Eva Verjans Germany

Raffaele Capoano Italy

Ingrid Yao Mattisson

196 ×1.5

IMMUN

112 ×0.9

43 ×0.7

RHEUM

47 ×0.8

CCM

89 ×1.6

EPIDE

Citations per year, relative to Ingrid Yao Mattisson Ingrid Yao Mattisson (= 1×) peers Raffaele Capoano

Countries citing papers authored by Ingrid Yao Mattisson

Since Specialization

Citations

This map shows the geographic impact of Ingrid Yao Mattisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Yao Mattisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Yao Mattisson more than expected).

Fields of papers citing papers by Ingrid Yao Mattisson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Yao Mattisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Yao Mattisson. The network helps show where Ingrid Yao Mattisson may publish in the future.

Co-authorship network of co-authors of Ingrid Yao Mattisson

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Yao Mattisson. A scholar is included among the top collaborators of Ingrid Yao Mattisson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Yao Mattisson. Ingrid Yao Mattisson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Mattisson, Ingrid Yao, et al.. (2023). Characterization and Efficacy of a Nanomedical Radiopharmaceutical for Cancer Treatment. ACS Omega. 8(2). 2357–2366. 1 indexed citations

Björnberg, Olof, et al.. (2023). Hydrofluoric Acid-Free Digestion of Organosilicon Nanoparticles for Bioanalysis by ICP-OES. SHILAP Revista de lepidopterología. 3(1). 264–273. 2 indexed citations

Spahic, Jasmina Medic, Ingrid Yao Mattisson, Viktor Hamrefors, et al.. (2023). Evidence for Impaired Renin Activity in Postural Orthostatic Tachycardia Syndrome. Journal of Clinical Medicine. 12(14). 4660–4660. 5 indexed citations

Mattisson, Ingrid Yao & Christina Christoffersen. (2021). Apolipoprotein M and its impact on endothelial dysfunction and inflammation in the cardiovascular system. Atherosclerosis. 334. 76–84. 31 indexed citations

Dunér, Pontus, Ingrid Yao Mattisson, Per Fogelstrand, et al.. (2021). Antibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE-/- mice. Scientific Reports. 11(1). 9022–9022. 16 indexed citations

Mattisson, Ingrid Yao, Sara Rattik, Harry Björkbacka, et al.. (2021). Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus. Vascular Pharmacology. 140. 106863–106863. 7 indexed citations

Gonçalves, Isabel, Pratibha Singh, Michele Cavalera, et al.. (2019). sTRAIL-R2 (Soluble TNF [Tumor Necrosis Factor]-Related Apoptosis-Inducing Ligand Receptor 2) a Marker of Plaque Cell Apoptosis and Cardiovascular Events. Stroke. 50(8). 1989–1996. 28 indexed citations

Dizeyi, Nishtman, et al.. (2019). The effects of Cernitin® on inflammatory parameters and benign prostatic hyperplasia: An in vitro study. Phytotherapy Research. 33(9). 2457–2464. 5 indexed citations

Wigren, Maria, Sara Rattik, Ingrid Yao Mattisson, et al.. (2019). Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE ^−/− Mice. Circulation. 139(22). 2554–2566. 35 indexed citations

10.

Rattik, Sara, Ingrid Yao Mattisson, Irena Ljungcrantz, et al.. (2018). B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice. Vascular Pharmacology. 111. 54–61. 6 indexed citations

11.

Wigren, Maria, Elisabet Svenungsson, Ingrid Yao Mattisson, et al.. (2018). Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis. Atherosclerosis. 270. 1–7. 26 indexed citations

12.

Mattisson, Ingrid Yao, Harry Björkbacka, Maria Wigren, et al.. (2017). Elevated Markers of Death Receptor-Activated Apoptosis are Associated with Increased Risk for Development of Diabetes and Cardiovascular Disease. EBioMedicine. 26. 187–197. 37 indexed citations

13.

Borné, Yan, Ingrid Yao Mattisson, Maria Wigren, et al.. (2017). FADD, Caspase-3, and Caspase-8 and Incidence of Coronary Events. Arteriosclerosis Thrombosis and Vascular Biology. 37(5). 983–989. 20 indexed citations

14.

Björkbacka, Harry, Ingrid Yao Mattisson, Maria Wigren, et al.. (2017). Plasma stem cell factor levels are associated with risk of cardiovascular disease and death. Journal of Internal Medicine. 282(6). 508–521. 26 indexed citations

15.

Asciutto, Giuseppe, Maria Wigren, Gunilla Nordin Fredrikson, et al.. (2016). Apolipoprotein B-100 Antibody Interaction With Atherosclerotic Plaque Inflammation and Repair Processes. Stroke. 47(4). 1140–1143. 14 indexed citations

16.

Rattik, Sara, Ingrid Yao Mattisson, Maria Wigren, et al.. (2016). Treatment with a GnRH receptor agonist, but not the GnRH receptor antagonist degarelix, induces atherosclerotic plaque instability in ApoE−/− mice. Scientific Reports. 6(1). 26220–26220. 41 indexed citations

17.

Swärd, Karl, Trần Thị Hiền, Ingrid Yao Mattisson, et al.. (2015). Regulation of Smooth Muscle Dystrophin and Synaptopodin 2 Expression by Actin Polymerization and Vascular Injury. Arteriosclerosis Thrombosis and Vascular Biology. 35(6). 1489–1497. 35 indexed citations

18.

Krawczyk, Katarzyna, Ingrid Yao Mattisson, Mari Ekman, et al.. (2015). Myocardin Family Members Drive Formation of Caveolae. PLoS ONE. 10(8). e0133931–e0133931. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact